Orchestra BioMed Holdings, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Orchestra BioMed Holdings, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Orchestra BioMed Holdings, Inc. do? Business model and key facts
Get the full picture of Orchestra BioMed Holdings, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 86
Orchestra BioMed Holdings, Inc. is an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company has formed strategic collaborations with Medtronic on BackBeat CNT and with Terumo Corporation on Virtue SAB. Its headquarters are located in New Hope, Pennsylvania.
Stocks related to Orchestra BioMed Holdings, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Orchestra BioMed Holdings, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Orchestra BioMed Holdings, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
